Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Clinical trial NCT04449549 · RECRUITING
Trial details
- NCT number
- NCT04449549
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-24
- Primary completion
- 2027-04-02
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.